Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Norepinephrine and glutamate are among several neurotransmitters implicated in the neuropathology of major depressive disorder (MDD). Glia deficits have also been demonstrated in people with MDD, and glia are critical modulators of central glutamatergic transmission. We studied glia in men with MDD in the region of the brain (locus coeruleus; LC) where noradrenergic neuronal cell bodies reside and receive glutamatergic input. Methods: The expression of 3 glutamate-related genes ( SLC1A3, SLC1A2, GLUL) concentrated in glia and a glia gene ( GFAP) were measured in postmortem tissues from men with MDD and from paired psychiatrically healthy controls. Initial gene expression analysis of RNA isolated from homogenized tissue ( n = 9–10 pairs) containing the LC were followed by detailed analysis of gene expressions in astrocytes and oligodendrocytes ( n = 6–7 pairs) laser captured from the LC region. We assessed protein changes in GFAP using immunohistochemistry and immunoblotting ( n = 7–14 pairs). Results: Astrocytes, but not oligodendrocytes, demonstrated robust reductions in the expression of SLC1A3 and SLC1A2, whereas GLUL expression was unchanged. GFAP expression was lower in astrocytes, and we confirmed reduced GFAP protein in the LC using immunostaining methods. Limitations: Reduced expression of protein products of SLC1A3 and SLC1A2 could not be confirmed because of insufficient amounts of LC tissue for these assays. Whether gene expression abnormalities were associated with only MDD and not with suicide could not be confirmed because most of the decedents who had MDD died by suicide. Conclusion: Major depressive disorder is associated with unhealthy astrocytes in the noradrenergic LC, characterized here by a reduction in astrocyte glutamate transporter expression. These findings suggest that increased glutamatergic activity in the LC occurs in men with MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Self-citationCellular changes in the postmortem hippocampus in major depression
Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.022 · Cited by 732 · cited 1×
“For the psychiatric assessment of our study sample, the next-of-kin completed the Structured Clinical Interview for DSM-IV psychiatric conditions (SCID) on behalf of the decedents, as described previously.(21,22) We also obtained brain tissues from 4 people from the Quebec Suicide Brain Bank at the Douglas Hospital Re…”
MethodSelf-citationThe STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Dumais, A., Lesage, A. D., Alda, M., Rouleau, G., Dumont, M., Chawky, N., Roy, M., Mann, J. J., Benkelfat, C., & Turecki, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2116 · Cited by 583 · cited 1×
“For the psychiatric assessment of our study sample, the next-of-kin completed the Structured Clinical Interview for DSM-IV psychiatric conditions (SCID) on behalf of the decedents, as described previously.(21,22) We also obtained brain tissues from 4 people from the Quebec Suicide Brain Bank at the Douglas Hospital Re…”
MethodSelf-citationRole of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Bernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372 · cited 14×
“The locus coeruleus (LC) in the pontine brainstem contains the cell bodies of the major source of norepinephrine in the brain and has been the subject of numerous investigations regarding the neuropathology of MDD.3 The human LC is an area with very high densities of radioligand binding of antidepressant drugs to mono…”
BackgroundResultInfluential
Research works printed but not linked: 38
- Kessler RC, 2003, JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
- Ordway GA, 2007, Brain norepinephrine, 341, 10.1017/CBO9780511544156.012 · doi:10.1017/cbo9780511544156.012
- Ordway GA, 1999, Brain Res, 847, 71, 10.1016/S0006-8993(99)02043-0 · DOI
- Klimek V, 1997, J Neurosci, 17, 8451, 10.1523/JNEUROSCI.17-21-08451.1997 · DOI · Paper page
- Klimek V, 2003, J Psychiatr Res, 37, 387, 10.1016/S0022-3956(03)00045-1 · DOI
- Wong ML, 2000, Proc Natl Acad Sci U S A, 97, 325, 10.1073/pnas.97.1.325 · DOI · Paper page
- Hashimoto K, 2007, Biol Psychiatry, 62, 1310, 10.1016/j.biopsych.2007.03.017 · DOI · Paper page
- Sanacora G, 2004, Arch Gen Psychiatry, 61, 705, 10.1001/archpsyc.61.7.705 · DOI · Paper page
- Singewald N, 1995, Brain Res, 704, 42, 10.1016/0006-8993(95)01102-1 · DOI
- Karolewicz B, 2004, J Neurochem, 91, 1057, 10.1111/j.1471-4159.2004.02792.x · DOI · Paper page
- Karolewicz B, 2005, Neuropsychopharmacology, 30, 1557, 10.1038/sj.npp.1300781 · DOI
- Altshuler LL, 2010, Bipolar Disord, 12, 541, 10.1111/j.1399-5618.2010.00838.x · DOI · Paper page
- Bowley MP, 2002, Biol Psychiatry, 52, 404, 10.1016/S0006-3223(02)01404-X · DOI · Paper page
- Kelly TM, 1996, Acta Psychiatr Scand, 94, 337, 10.1111/j.1600-0447.1996.tb09869.x · DOI · Paper page
- Austin MC, 2002, Neuroscience, 114, 807, 10.1016/S0306-4522(02)00289-0 · DOI
- Ordway GA, 2012, Int J Neuropsychopharmacol, 15, 855, 10.1017/S1461145711001350 · DOI
- Ordway GA, 2009, J Neurosci Res, 87, 2430, 10.1002/jnr.22078 · DOI
- Xiang L, 2008, Brain Res, 1207, 214, 10.1016/j.brainres.2008.02.009 · DOI
- Pitt D, 2003, Neurology, 61, 1113, 10.1212/01.WNL.0000090564.88719.37 · DOI · Paper page
- Fleige S, 2006, Biotechnol Lett, 28, 1601, 10.1007/s10529-006-9127-2 · DOI · Paper page
- Jen JC, 2005, Neurology, 65, 529, 10.1212/01.WNL.0000172638.58172.5a · DOI · Paper page
- Rao JS, 2012, J Affect Disord, 136, 63, 10.1016/j.jad.2011.08.017 · DOI · Paper page
- Bechtholt-Gompf AJ, 2010, Neuropsychopharmacology, 35, 2049, 10.1038/npp.2010.74 · DOI · Paper page
- Lee SG, 2008, J Biol Chem, 283, 13116, 10.1074/jbc.M707697200 · DOI · Paper page
- Mineur YS, 2007, Biol Psychiatry, 61, 250, 10.1016/j.biopsych.2006.04.037 · DOI
- Fumagalli E, 2008, Eur J Pharmacol, 578, 171, 10.1016/j.ejphar.2007.10.023 · DOI · Paper page
- Gittins RA, 2011, J Affect Disord, 133, 328, 10.1016/j.jad.2011.03.042 · DOI
- Davis S, 2002, J Neurol Neurosurg Psychiatry, 73, 556, 10.1136/jnnp.73.5.556 · DOI · Paper page
- Si X, 2004, Neuropsychopharmacology, 29, 2088, 10.1038/sj.npp.1300525 · DOI · Paper page
- Fatemi SH, 2004, Schizophr Res, 69, 317, 10.1016/j.schres.2003.08.014 · DOI · Paper page
- Gosselin RD, 2009, Neuroscience, 159, 915, 10.1016/j.neuroscience.2008.10.018 · DOI · Paper page
- Hösli L, 1982, Neuroscience, 7, 2867, 10.1016/0306-4522(82)90109-9 · DOI
- Fahrig T, 1993, Glia, 7, 212, 10.1002/glia.440070304 · DOI
- Hansson E, 1992, Brain Res Bull, 29, 297, 10.1016/0361-9230(92)90060-B · DOI
- Aston-Jones G, 1986, Science, 234, 734, 10.1126/science.3775363 · DOI · Paper page
- Valentino RJ, 2001, Neuroscience, 106, 375, 10.1016/S0306-4522(01)00279-2 · DOI
- Perea G, 2010, Brain Res Rev, 63, 93, 10.1016/j.brainresrev.2009.10.005 · DOI · Paper page
- Banasr M, 2008, Biol Psychiatry, 64, 863, 10.1016/j.biopsych.2008.06.008 · DOI · Paper page
Cited by
Turecki, G., Brent, D. A., Gunnell, D., O’Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0121-0 · Cited by 1,074
Self-citationEnache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
“We included 24 studies which assessed astrocytes in postmortem brains of patients with MDD (Altshuler et al., 2010; Barley et al., 2009; Bernard et al., 2011; Chandley et al., 2013; Cobb et al., 2016; Damadzic et al., 2001; Davis et al., 2002; Fatemi et al., 2004; Gos et al., 2013; Miguel-Hidalgo et al., 2014, 2011, 2…”
BackgroundInfluentialAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
Self-citationCobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254
Self-citationHuman astrocytes in the diseased brain
Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Neuropathology of mood disorders: Do we see the stigmata of inflammation?
Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165
Neuropathology of suicide: Recent findings and future directions
Lutz, P.-E., Mechawar, N., & Turecki, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.141 · Cited by 158
Self-citationTorres-Platas, S. G., Nagy, C., Wakid, M., Turecki, G., & Mechawar, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.65 · Cited by 148
Self-citationNagy, C., Torres-Platas, S. G., Mechawar, N., & Turecki, G. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw071 · Cited by 98
Self-citationYin, H., Pantazatos, S. P., Galfalvy, H., Huang, Y., Rosoklija, G. B., Dwork, A. J., Burke, A., Arango, V., Oquendo, M. A., & Mann, J. J. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32423 · Cited by 91
Kong, H., Zeng, X., Fan, Y., Yuan, S., Ge, S., Xie, W., Wang, H., & Hu, G. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12222 · Cited by 72
Szebeni, A., Szebeni, K., DiPeri, T. P., Johnson, L. A., Stockmeier, C. A., Crawford, J. D., Chandley, M. J., Hernandez, L. J., Burgess, K. C., Brown, R. W., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw114 · Cited by 57
Self-citationZhang, L., Verwer, R. W. H., Zhao, J., Huitinga, I., Lucassen, P. J., & Swaab, D. F. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.098 · Cited by 40
Structural abnormality of the hippocampus associated with depressive symptoms in heart failure rats
Suzuki, H., Sumiyoshi, A., Matsumoto, Y., Duffy, B. A., Yoshikawa, T., Lythgoe, M. F., Yanai, K., Taki, Y., Kawashima, R., & Shimokawa, H. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.10.040 · Cited by 35
Metadata
- Authors
- Chandley, M. J., Szebeni, K., Szebeni, A., Crawford, J., Stockmeier, C. A., Turecki, G., Miguel-Hidalgo, J. J., & Ordway, G. A.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2013-07
- Volume
- 38
- Issue
- 4
- Pages
- 276-284
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W1965556606
- Cited by
- 99
- References
- 17
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.